Cao Bo, Passos Ives Cavalcante, Mwangi Benson, Bauer Isabelle E, Zunta-Soares Giovana B, Kapczinski Flávio, Soares Jair C
UT Center of Excellence on Mood Disorder, Department of Psychiatry and Behavioral Sciences, The University of Texas Science Center at Houston, Houston, TX, USA.
Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
J Psychiatr Res. 2016 Feb;73:102-107. doi: 10.1016/j.jpsychires.2015.12.012. Epub 2015 Dec 15.
Studies about changes in hippocampal volumes in subjects with bipolar disorder (BD) have been contradictory. Since the number of manic episodes and hospitalization has been associated with brain changes and poor cognitive outcomes among BD patients, we have hypothesized that these variables could clarify this issue. We stratified subjects with BD in early (BD-Early), intermediate (BD-intermediate) and late (BD-Late) stages as a function of number of manic episodes and prior hospitalization. Then, we compared their hippocampal volumes and California Verbal Learning Test-II (CVLT-II) scores with healthy controls (HC) using the general linear model. A total of 173 subjects were included in the study (112 HC, 15 BD-Early, 30 BD-Intermediate, and 16 BD-Late). We found a significant group effect on hippocampus volume (F(3,167) = 3.227, p = 0.024). Post-hoc analysis showed that BD-Late subjects had smaller hippocampus than HC (p = 0.017). BD-Early and BD-Intermediate subjects showed no significant difference in hippocampus volume compared to HC and BD-Late subjects. The CVLT trial 1 to 5 scores were significantly different across the groups (F(3,167) = 6.371, p < 0.001). Post-hoc analysis showed that BD-Intermediate (p = 0.006) and BD-Late (p = 0.017) subjects had worse memory performance during immediate recall than HC, while the performance difference between BD-Early subjects and HC was not significant (p = 0.208). These findings add to the notion that BD is a neuroprogressive disorder with brain changes and cognitive impairment according to prior morbidity (number of manic episodes and hospitalization). Also, they suggest that hippocampus is a brain marker and a potential therapeutic target for patients at late stage.
关于双相情感障碍(BD)患者海马体体积变化的研究结果相互矛盾。由于躁狂发作次数和住院情况与BD患者的大脑变化及认知预后不良有关,我们推测这些变量可能有助于阐明这一问题。我们根据躁狂发作次数和既往住院情况,将BD患者分为早期(BD-早期)、中期(BD-中期)和晚期(BD-晚期)。然后,我们使用一般线性模型将他们的海马体体积和加利福尼亚言语学习测验第二版(CVLT-II)分数与健康对照组(HC)进行比较。共有173名受试者纳入研究(112名HC,15名BD-早期,30名BD-中期,16名BD-晚期)。我们发现,组间在海马体体积上存在显著差异(F(3,167) = 3.227,p = 0.024)。事后分析表明,BD-晚期患者的海马体比HC小(p = 0.017)。与HC和BD-晚期患者相比,BD-早期和BD-中期患者的海马体体积无显著差异。CVLT第1至5次试验的分数在各组间存在显著差异(F(3,167) = 6.371,p < 0.001)。事后分析表明,BD-中期(p = 0.006)和BD-晚期(p = 0.017)患者在即时回忆时的记忆表现比HC差,而BD-早期患者与HC之间的表现差异不显著(p = 0.208)。这些发现进一步支持了以下观点:根据既往发病情况(躁狂发作次数和住院情况),BD是一种具有大脑变化和认知障碍的神经进行性疾病。此外,它们还表明,海马体是晚期患者的一个大脑标志物和潜在治疗靶点。